Folate comes in various forms, including folinic acid and folic acid. Each form has a different absorption rate and clinical uses.
At week 24, no significant difference in PASDAS was observed between the golimumab and methotrexate group and the placebo and methotrexate group. More participants in the placebo and methotrexate ...
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognised useful secondary effect to lower blood pressure and potentially reduces the risk of heart disease in people ...
For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks, the randomized PREDMETH trial showed. Mean change from baseline in the ...
Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International ...
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer JCOG0905 is a multicenter, open-label, multi-institutional, randomized trial ...
In patients with methotrexate osteopathy (MTXO) insufficiency fractures, continuing MTX led to a significantly higher risk for subsequent fractures, with nearly all patients who continued MTX ...
Methotrexate is a generic drug prescribed to treat certain types of cancers, arthritis, and psoriasis in adults and some children. As with other drugs, methotrexate can cause side effects, such as ...
Researchers evaluated the impact of different treatment modalities in the prevention of psoriatic arthritis (PsA). Biological agents were found more effective than methotrexate in preventing psoriatic ...
Methotrexate is a generic drug prescribed for certain conditions, such as rheumatoid arthritis and some cancers. The cost of methotrexate with and without insurance can depend on several factors, such ...
Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...
Nov 7 (Reuters) - The U.S. Food and Drug Administration (FDA) reported on Tuesday Accord Healthcare has resumed manufacturing of methotrexate, one of the most commonly used cancer drugs, amid ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results